StreetInsider

• Log in to your account:

  
  Log in
• Signup
• Home
• EPS Insider
• Event Calendar
• Conferences
• Classic Site

Upgrade to SI Premium - Free Trial

Lantern Pharma (LTRN)

New to The Street Broadcasts at 6:30 PM ET Across Bloomberg U.S., Latin America and MENA, Featuring Lantern Pharma (NASDAQ:LTRN), SafeSpace Global (OTCID:SSGC) and FreeCast (NASDAQ:CAST) September 5, 2026 10:51 AM - StreetInsider New to The Street Broadcasting Today at 6:30 PM EST on Bloomberg Television Across the U.S., Latin America and MENA-Featuring FreeCast (NASDAQ: CAST), Metaterra Holdings (MTHI) and SafeSpace Global (S August 29, 2026 9:23 AM - StreetInsider Form 8-K Lantern Pharma Inc. For: Aug 14 August 14, 2026 7:36 AM - SEC Filing Form 10-Q Lantern Pharma Inc. For: Jun 30 August 14, 2026 7:31 AM - SEC Filing Lantern Pharma Reports Second Quarter 2026 Financial Results and Provides Business Update August 14, 2026 7:30 AM - BizWire New to The Street Show 766 Broadcasts Tonight at 6:30 PM ET on Bloomberg Television, Featuring BioVie's Bezisterim Parkinson's Disease Clinical Results August 8, 2026 12:01 PM - StreetInsider Lantern Pharma to Report Second Quarter 2026 Operating & Financial Results on August 14th, 2026 at 9:00 a.m. ET August 7, 2026 8:00 AM - BizWire Form SCHEDULE 13G Lantern Pharma Inc. Filed by: Empery Asset Management, LP August 4, 2026 10:04 AM - SEC Filing Form 8-K Lantern Pharma Inc. For: Aug 03 August 3, 2026 5:25 PM - SEC Filing Lantern Pharma spins out AI platform into separate company August 3, 2026 7:31 AM - StreetInsider Lantern Pharma (Nasdaq: LTRN) Establishes Open-Medicine AI as a Separate Company to Commercialize and Expand Its Multi-Agent AI Co-Scientist Platform for the Transformation of Medicine August 3, 2026 7:30 AM - BizWire Lantern Pharma gets EMA clearance for bladder cancer drug trial July 28, 2026 7:45 AM - StreetInsider Lantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer July 28, 2026 7:45 AM - BizWire New to The Street to Broadcast Nationwide on Bloomberg Television Tonight at 6:30 PM ET Featuring RHINO Bitcoin, Marina Decisions, Medicus Pharma and Virtuix Holdings July 25, 2026 1:10 PM - StreetInsider Form SCHEDULE 13G/A Lantern Pharma Inc. Filed by: SATTERFIELD THOMAS A JR July 23, 2026 1:47 PM - SEC Filing Lantern Pharma receives USPTO patent allowance for LP-184 biomarker July 23, 2026 8:01 AM - StreetInsider Lantern Pharma Receives USPTO Notice of Allowance for Patent Covering Biomarker-Guided Treatment with LP-184 (Zirdafulven) in Multiple Solid Tumor Cancers July 23, 2026 8:01 AM - BizWire New to The Street(R) to Broadcast Show #762 Tonight on Bloomberg Television at 6:30 PM ET, Featuring Envoy Medical (NASDAQ:COCH), AlphaCompute (NASDAQ:ALP), RHINO Bitcoin (OTC PINK:RHNO), and Big Sky July 18, 2026 12:40 PM - StreetInsider New to The Street Show #761 to Broadcast Across Bloomberg U.S., Latin America and MENA, Featuring Sagtec Global, Virtuix, Lantern Pharma and YY Group July 11, 2026 12:30 PM - StreetInsider Lantern Pharma launches ZetaOmics cancer bioinformatics tool July 8, 2026 7:30 AM - StreetInsider Lantern Pharma Launches ZetaOmics™ — an Autonomous, Intelligent “Computational Biologist” That Brings Expert-Grade Bioinformatics, Biostatistics & Reasoning to Every Cancer July 8, 2026 7:30 AM - BizWire New to The Street Show #760 Airs Tonight on Bloomberg Television Across the U.S. on Independence Day Featuring Sullivan & Cromwell’s Frank Aquila, Medicus Pharma, PetVivo, FreeCast and YY Group July 4, 2026 12:27 PM - StreetInsider New to The Street Announces Broadcast of Show #759 on Bloomberg Television Across the U.S., MENA and Latin America tonight 630pm est. June 27, 2026 2:40 PM - StreetInsider Form EFFECT Lantern Pharma Inc. June 22, 2026 6:03 AM - SEC Filing Lantern Pharma (LTRN) files for 2.24M share offering by selling stockholders June 12, 2026 4:39 PM - StreetInsider Form S-1 Lantern Pharma Inc. June 12, 2026 4:31 PM - SEC Filing Full Article List